SIPONIMOD

Trials studying SIPONIMOD

• —A Study to Learn More About The Safety of Diroximel Fumarate (VUMERITY®) in Participants Who Took it During Pregnancy And About the Health of Their Babiesactive not recruitingn=1,178
• phase3Efficacy and Safety of Ofatumumab and Siponimod Compared to Fingolimod in Pediatric Patients With Multiple Sclerosisactive not recruitingn=129
• phase2Repurposing Siponimod for Alzheimer's Diseaserecruitingn=105
• —Impact of Mayzent on aSPMS Patients in a Long-term NIS in Italycompletedn=134
• —Managed Access Program (MAP) for Patients Diagnosed With Secondary Progressive Multiple Sclerosis With Active Diseaseno longer available
• phase3Safety and Tolerability of Conversion From Oral, Injectable, or Infusion Disease Modifying Therapies to Dose-titrated Oral Siponimod (Mayzent) in Advancing RMS Patientscompletedn=185
• —Post-Authorization Safety Study for Assessment of Pregnancy Outcomes in Patients Treated With Mayzentrecruitingn=867
• —Swiss Study of the Impact of Mayzent on SPMS Patients in a Long-term Non-interventional Studyterminatedn=8